Author

Yasmena O. Azar

Observed name: Yasmena O Azar

Institution: Sinai University

Observed institution: Sinai University

ORCID: 0000-0002-0591-1124

Observed ORCID: 0000-0002-0591-1124

OpenAlex ID: A5079056722

Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1/RAGE/TLR4/MYD88/NF-κB signaling cascade in rotenone lesioned rats

2022 · Yasmena O. Azar, Ghada A. Badawi, et al. · Life Sciences · 32

Probiotics and the Gut–Brain Axis: Emerging Therapeutic Strategies for Epilepsy and Depression Comorbidity

2025 · Mustafa M. Shokr, Reem M. Eladawy, et al. · Foods · 25

The Future of Alopecia Treatment: Plant Extracts, Nanocarriers, and 3D Bioprinting in Focus

2025 · Rana E. Elnady, Manar S. Abdon, et al. · Pharmaceutics · 20

Exploring the Therapeutic Potential of Allium cepa and Allium sativum Extracts: Current Strategies, Emerging Applications, and Sustainability Utilization

2025 · Alaa S. Bedir, Razan S. Almasri, et al. · Biology · 19

Targeting α-Klotho Protein by Agmatine and Pioglitazone Is a New Avenue against Diabetic Nephropathy

2025 · Yasmena O. Azar, Sherehan M. Ibrahim, et al. · ACS Pharmacology & Translational Science · 3

Depression in Autism Spectrum Disorder: Neurobiological Convergence and Emerging Therapeutic Strategies

2026 · Seham M. Al Raish, Mustafa M. Shokr, et al. · Biology · 1

Fasting is a Promising Supportive Therapy for the Treatment of Cancer Patients

2026 · Nancy M Abdel-Kareem, Shrouk M Basiouny, et al. · SINAI International Scientific Journal.

Works count: 7

Citation count: 100

H-index: 4

I10-index: 4